We are live on ! Find out more
AHG

Akso Health Group
AHG

4 hedge funds and large institutions have $829K invested in Akso Health Group in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more capital invested

Capital invested by funds: $575K → $829K (+$254K)

33% more funds holding

Funds holding: 3 → 4 (+1)

0.03% more ownership

Funds ownership: 0.68% → 0.71% (+0.03%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$40K
2
UBS Group
UBS Group
Switzerland
+$67

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$16.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$785K +$40K +24,014 +7%
Citadel Advisors
2
Citadel Advisors
Florida
$34K -$16.6K -9,955 -39%
Morgan Stanley
3
Morgan Stanley
New York
$10K – – –
UBS Group
4
UBS Group
Switzerland
– +$67 +40 New

AHG Hedge Fund Activity: Q3 2021 in Review

4 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q3 2021, worth a combined $829K — up 44% from $575K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new AHG positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $40K. The largest seller was Citadel Advisors, cutting an estimated $16.6K.

  • 4 institutional investors held Akso Health Group (AHG) as of Q3 2021, up from 3 in Q2 2021.
  • Funds reported $829K of Akso Health Group stock for Q3 2021, up 44% quarter-over-quarter.
  • 1 fund opened new Akso Health Group positions in Q3 2021 and 0 closed out, a net change of +1 holder.
  • The largest Akso Health Group buyer in Q3 2021 was Renaissance Technologies, an estimated $40K added.
  • The largest Akso Health Group seller in Q3 2021 was Citadel Advisors, an estimated $16.6K sold.

Based on aggregated 13F filings for Q3 2021.